Skip to content

Modified femoral nerve block reduces thigh tourniquet-induced hypertension

Modified femoral nerve block reduces thigh tourniquet-induced hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060376
Enrollment
Unknown
Registered
2022-05-29
Start date
2022-06-15
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tourniquet-induced hypertension

Interventions

Group 1 :0.5% ropivacaine 20 ml femoral nerve block + 10 ml femoral artery block
Group 2:0.5% ropivacaine 30 ml femoral nerve block

Sponsors

The Third Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Planned elective high tibial osteotomy; 2. ASA I-II level; 3. Age 40-70 years old; 4. The anesthesia method is general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Chronic pain and long-term use of opioids; 2. Infection at the block site; 3. Hypersensitivity to local anesthetics; 4. Ischemic heart disease or uncontrolled hypertension; 5. Tourniquet contraindications (peripheral vascular disease, popliteal artery calcification, history of arterial bypass grafting, peripheral neuropathy); 6. There are language barriers, hearing barriers or visual barriers; 7. Alcohol or drug dependence; 8. Tourniquet inflation time > 150 minutes or < 60 minutes.

Design outcomes

Primary

MeasureTime frame
Incidence of tourniquet hypertension;

Secondary

MeasureTime frame
Intraoperative dosage of antihypertensive drugs;Dosage of opioid analgesic used during operation;Visual analogue scale score for pain;Patient satisfaction score;

Countries

China

Contacts

Public ContactQiujun Wang

The Third Hospital of Hebei Medical University

13933178001@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026